Women taking the drug reported between 0.5 and one more sexually satisfying event per month, results experts admitted were "modest".
It's a new dawn in female sexual relations as a United States government panel has urged regulators to approve a drug to treat low sexual desire in women, nicknamed the "female Viagra".
According to BBC, experts backed flibanserin, but said it must carry warnings about strong possible side effects including fainting and tiredness.
It's a new dawn in female sexual relations as a United States government panel has urged regulators to approve a drug to treat low sexual desire in women, nicknamed the "female Viagra".
According to BBC, experts backed flibanserin, but said it must carry warnings about strong possible side effects including fainting and tiredness.